Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Hiroki WatanabeNeiko OzasaTakeshi MorimotoHiroki ShiomiBao BingyuanSatoru SuwaYoshihisa NakagawaChisato IzumiKazushige KadotaShigeru IkeguchiKiyoshi HibiYutaka FurukawaShuichiro KajiTakahiko SuzukiMasaharu AkaoTsukasa InadaYasuhiko HayashiMamoru NanasatoMasaaki OkutsuRyosuke KametaniTakahito SoneYoichi SugimuraKazuya KawaiMitsunori AbeHironori KanekoSunao NakamuraTakeshi Kimuranull nullPublished in: PloS one (2018)
CAPITAL-RCT (Carvedilol Post-Intervention Long-Term Administration in Large-scale Randomized Controlled Trial) ClinicalTrials.gov.number, NCT 01155635.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- randomized controlled trial
- acute coronary syndrome
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- antiplatelet therapy
- coronary artery bypass grafting
- study protocol
- coronary artery bypass
- systematic review
- newly diagnosed